Mesoblast (MESO) Net Margin (2014 - 2023)
Mesoblast's Net Margin was -47.82% in the year ended Jun 30, 2026, up 546.10 percentage points from -593.92% a year earlier.
Powered by 
Analysis
Mesoblast (MESO) Net Margin (2014 - 2023) Analysis & Trends
From the year ended Jun 30, 2015 onward, Mesoblast has reported Net Margin for 12 years.
- Net Margin shows a five-year change of +1281.36 percentage points (years ended Jun 2021 to Jun 2026).
- The figure for the year ended Jun 30, 2026 marks the highest annual Net Margin since the year ended Jun 30, 2016.
- Per Business Quant data, Net Margin in earlier years was -593.92% in the year ended Jun 30, 2025 (+896.36 pp), -1490.27% in the year ended Jun 30, 2024 (-398.57 pp), -1091.71% in the year ended Jun 30, 2023 (-197.11 pp) and -894.59% in the year ended Jun 30, 2022 (+434.58 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -1.65% |
| 10 | Mesoblast | 1.66 Bn | 1.23 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -1,024.73% |
| Mar 31, 2023 | -959.26% |
| Dec 31, 2022 | -1,147.42% |
| Sep 30, 2022 | -1,123.35% |
| Jun 30, 2022 | -964.70% |
| Mar 31, 2022 | -1,059.27% |
| Dec 31, 2021 | -1,088.75% |
| Sep 30, 2021 | -630.08% |
| Jun 30, 2021 | -1,118.09% |
| Mar 31, 2021 | -1,354.19% |
| Dec 31, 2020 | -1,146.45% |
| Sep 30, 2020 | -1,880.77% |
| Jun 30, 2020 | -4,651.93% |
| Mar 31, 2020 | -125.10% |
| Dec 31, 2019 | -1,114.42% |
| Sep 30, 2019 | -32.17% |
| Jun 30, 2019 | -1,053.69% |
| Mar 31, 2019 | -1,999.20% |
| Dec 31, 2018 | -1,315.72% |
| Sep 30, 2018 | -167.55% |
API Access
Mesoblast Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();